These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23547873)

  • 1. Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.
    Qian M; Jin W; Zhu X; Jia X; Yang X; Du Y; Wang K; Zhang J
    J Hematol Oncol; 2013 Apr; 6():25. PubMed ID: 23547873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
    Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
    Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
    Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
    Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
    Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
    Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Zou D; Yang X; Tan Y; Wang P; Zhu X; Yang W; Jia X; Zhang J; Wang K
    Leuk Res; 2012 Feb; 36(2):219-23. PubMed ID: 21993313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of low PU.1 expression in patients with acute promyelocytic leukemia.
    Zhu X; Zhang H; Qian M; Zhao X; Yang W; Wang P; Zhang J; Wang K
    J Hematol Oncol; 2012 May; 5():22. PubMed ID: 22569057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells.
    Zhu Y; Zhang F; Zhang S; Deng W; Fan H; Wang H; Zhang J
    Front Med; 2017 Mar; 11(1):87-96. PubMed ID: 28063140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 controls the expression of long noncoding RNA HOTAIRM1 during granulocytic differentiation.
    Wei S; Zhao M; Wang X; Li Y; Wang K
    J Hematol Oncol; 2016 May; 9(1):44. PubMed ID: 27146823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
    Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
    J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.
    Federzoni EA; Valk PJ; Torbett BE; Haferlach T; Löwenberg B; Fey MF; Tschan MP
    Blood; 2012 May; 119(21):4963-70. PubMed ID: 22498738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation.
    Brugnoli F; Lambertini E; Varin-Blank N; Piva R; Marchisio M; Grassilli S; Miscia S; Capitani S; Bertagnolo V
    Exp Cell Res; 2010 Jan; 316(1):38-47. PubMed ID: 19747912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML-RARα interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia.
    Yang X; Tan Y; Wang P; Zhang H; Zhao M; Zhao X; Wang K
    J Cell Mol Med; 2018 Dec; 22(12):6275-6284. PubMed ID: 30320491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
    Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
    Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.
    Wang X; Tan Y; Li Y; Li J; Jin W; Wang K
    Front Med; 2016 Dec; 10(4):420-429. PubMed ID: 27888400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [JMJD3 Exerts Oncorepressor Activity in Acute Promyelocytic Leukemia by Promoting PU.1 Expression].
    -Xi Wang M; -He Yu S; Xiao M; Chen J
    Mol Biol (Mosk); 2023; 57(4):665-667. PubMed ID: 37528785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells.
    Vezzali F; Grassilli S; Lambertini E; Brugnoli F; Patergnani S; Nika E; Piva R; Pinton P; Capitani S; Bertagnolo V
    J Cell Mol Med; 2018 Jun; 22(6):3149-3158. PubMed ID: 29532991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells.
    De Marchis ML; Ballarino M; Salvatori B; Puzzolo MC; Bozzoni I; Fatica A
    Leukemia; 2009 May; 23(5):856-62. PubMed ID: 19151778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.